|
Neonatal Intensive Care Drug Manual
|
| bet | 471/654 | | Sana | 03.01.2022 | | Hajmi | 1,5 Mb. | | #14803 |
Contraindications
|
Hyperphosphataemia, dehydration, severe renal insufficiency, shock.
|
Precautions
|
Hypernatraemia (avoid sodium dihydrogen phosphate).
Hyperkalaemia (avoid potassium dihydrogen phosphate)
|
Drug Interactions
|
Calcium and magnesium antacids (e.g. acetate, carbonate, citrate, hydroxide etc.) reduce phosphate absorption — separate doses by at least 2 hours.
Additive effects with other drugs that may prolong QT interval.
Potassium dihydrogen phosphate preparation may increase the risk of hyperkalaemia when used in conjunction with potassium sparing diuretics (e.g. spironolactone).
|
|
|
| |
